HRT: Complete Guide to Testosterone Replacement Therapy

⚠️ IMPORTANT MEDICAL WARNING

This material is for **educational purposes only** and is not medical advice, prescription, or guidance for action.

**Hormone Replacement Therapy (HRT/TRT) is a serious medical intervention** that should only be conducted under the supervision of a qualified endocrinologist or urologist-andrologist.

What you should understand:

1. **Self-treatment with hormones is dangerous** — incorrect dosages, lack of monitoring, and ignoring contraindications can lead to serious health consequences.

1. **Before starting any therapy, you need**:

• Complete medical examination
• Hormonal profile tests
• Exclusion of contraindications
• Individual protocol selection

1. **Testosterone is a controlled substance** in most countries. Its purchase, storage, and use without a prescription may be illegal.

Scientific Sources

Material is based on recommendations from:

• Endocrine Society Clinical Practice Guidelines
• American Urological Association Guidelines
• PubMed Central — NIH

The authors are not responsible for any actions taken based on this material.

Why Biohackers Turn to HRT

Testosterone Replacement Therapy (TRT) is one of the most studied and effective tools for optimizing male health. In the biohacking context, the goal of TRT is not achieving supraphysiological levels (as in bodybuilding), but **restoring optimal physiological values**.

Biohacking ≠ Bodybuilding

| Aspect | Biohacking | Bodybuilding | |--------|-----------|-------------| | **Goal** | Optimal health | Maximum muscle mass | | **Dosages** | Physiological (100-200 mg/week) | Supraphysiological (500+ mg/week) | | **Monitoring** | Regular, comprehensive | Often minimal | | **Duration** | Long-term therapy | Cycles | | **Risk approach** | Minimization | Often ignored |

Key TRT Goals in Biohacking

1. **Energy and cognitive function** — optimal testosterone correlates with mental clarity and productivity
2. **Body composition** — maintaining muscle mass, fat control
3. **Libido and sexual function** — one of the most noticeable therapy effects
4. **Mood and motivation** — stable levels reduce depression risk
5. **Cardiometabolic health** — properly selected therapy can improve lipid profile

When to Consider TRT

Indications for examination:

• Deficiency symptoms (fatigue, decreased libido, cognitive fog)
• Laboratory-confirmed low testosterone (< 300-350 ng/dL)
• Age 30+ with progressive decline
• No effect from lifestyle interventions

Testosterone Physiology

Testosterone is the primary male sex hormone, key to many body functions.

Where It's Produced

• **95% — testes** (Leydig cells)
• **5% — adrenal glands**
• In women: ovaries and adrenal glands (in smaller amounts)

Regulation: HPG Axis (Hypothalamus-Pituitary-Gonad)

``` Hypothalamus → GnRH → Pituitary → LH/FSH → Testes → Testosterone ↓ Negative feedback loop ```

1. **GnRH** (gonadotropin-releasing hormone) — signal from hypothalamus
2. **LH** (luteinizing hormone) — stimulates testosterone production
3. **FSH** (follicle-stimulating hormone) — stimulates spermatogenesis

Forms of Testosterone in Blood

| Form | % of total | Function | |------|------------|----------| | **SHBG-bound** | 44-65% | Inactive, transport form | | **Albumin-bound** | 33-54% | Weakly bound, available to tissues | | **Free** | 1-3% | Biologically active |

**Bioavailable testosterone** = Free + Albumin-bound

Why Levels Decline

1. **Age** — approximately -1-2% per year after 30
2. **Obesity** — fat tissue contains aromatase (conversion to estradiol)
3. **Chronic stress** — cortisol suppresses HPG axis
4. **Sleep deprivation** — main production occurs during sleep
5. **Endocrine disruptors** — plastic, pesticides, phthalates
6. **Chronic diseases** — diabetes, metabolic syndrome

Deficiency Symptoms

Physical:

• Fatigue, decreased energy
• Loss of muscle mass
• Increased fat tissue
• Decreased libido
• Erectile dysfunction

Cognitive/Emotional:

• Brain fog
• Decreased motivation
• Irritability or apathy
• Depressive symptoms

What Are Esters and Why They're Needed

Pure testosterone has a half-life of only **2-4 hours** — making it impractical for therapy. Esters are chemical modifications that slow hormone release.

How Esters Work

1. **Injection** — testosterone ester is injected into muscle or subcutaneously
2. **Depot** — an oil depot forms at the injection site
3. **Release** — ester gradually releases into bloodstream
4. **Hydrolysis** — enzymes (esterases) cleave the ester group
5. **Active testosterone** — free testosterone becomes bioavailable

Key Characteristics

• **Half-life** — time for concentration to decrease by half
• **Injection frequency** — depends on half-life
• **Level stability** — longer esters = more stable levels with proper frequency
• **Molecular weight** — affects amount of active testosterone per mg

Calculating Active Testosterone

Not all ester weight is testosterone:

| Ester | % active T | 100 mg contains | |-------|------------|-----------------| | Propionate | 83.7% | 83.7 mg T | | Enanthate | 72% | 72 mg T | | Cypionate | 69.9% | 69.9 mg T | | Undecanoate | 61.4% | 61.4 mg T |

Carrier Oils

Medications are dissolved in oil (affects tolerability):

• **Sesame oil** — most common
• **Castor oil** — used in Nebido
• **Cottonseed oil** — some generics
• **MCT/Miglyol** — faster absorption, fewer reactions

Ester Comparison Table

| Ester | Half-life | Injection Freq. | Stability | Notes | |-------|-----------|-----------------|-----------|-------| | **Enanthate** | 4-5 days | 1-2x/week | ★★★★☆ | TRT gold standard | | **Cypionate** | 5-8 days | 1-2x/week | ★★★★☆ | Popular in USA | | **Propionate** | 0.8-1 day | Daily | ★★★★★ | Fast action, frequent shots | | **Sustanon** | Mixed | 1-2x/week | ★★★☆☆ | 4-ester blend | | **Undecanoate** | 20-21 days | 1x/10-14 wks | ★★★☆☆ | Nebido, rare injections |

Testosterone Enanthate

**TRT gold standard** — most studied and widely used ester.

Characteristics

• Half-life: **4-5 days**
• Peak concentration: 24-48 hours post-injection
• Recommended frequency: **1-2 times per week**

Dosage

• **50-200 mg/week** (or 50-100 mg 2 times per week), depending on lab results
• **Subcutaneous**: Many patients switch to SubQ with smaller volumes

Advantages

• Extensive evidence base
• Predictable pharmacokinetics
• Availability and cost
• Well tolerated by most

Testosterone Cypionate

Virtually identical to enanthate, **dominates in USA**.

Characteristics

• Half-life: **5-8 days** (slightly longer than enanthate)
• Peak concentration: 24-48 hours
• Recommended frequency: **1-2 times per week**

Dosage

• **50-200 mg/week** (or 50-100 mg 2 times per week), depending on lab results

Differences from Enanthate

• Slightly longer half-life
• Slightly less active testosterone per mg (69.9% vs 72%)
• Interchangeable in clinical practice

Testosterone Propionate

**Short-acting ester** — for those wanting maximum control.

Characteristics

• Half-life: **0.8-1 day**
• Peak: 4-6 hours post-injection
• Frequency: **Daily injections**

When Used

• Starting period (rapid effect assessment)
• Maximum stable levels
• Minimizing aromatization

Disadvantages

• Daily injections
• More frequent injection site irritation

Sustanon (Omnadren)

**4-ester blend** — theoretically for "smooth" levels, practically — not the best choice.

Composition (250 mg/mL)

• Propionate: 30 mg
• Phenylpropionate: 60 mg
• Isocaproate: 60 mg
• Decanoate: 100 mg

Problems

• Different half-lives create unstable curve
• Marketing product, not optimal for TRT
• Requires frequent injections for stability

Testosterone Undecanoate (Nebido)

**Ultra-long ester** — injections once every 10-14 weeks.

Characteristics

• Half-life: **20-21 days**
• Injections: **1000 mg every 10-14 weeks**
• Volume: 4 mL (intramuscular only)

Advantages

• Minimal injection frequency
• Convenience for some patients

Disadvantages

• Unstable levels (peaks and troughs)
• Large injection volume
• Harder to titrate dose
• High cost

Compounds for TRT Optimization

In addition to testosterone itself, TRT protocols often include additional medications.

hCG (Human Chorionic Gonadotropin)

**Why**: Maintaining testicular function and spermatogenesis during TRT.

How It Works

• Mimics LH (luteinizing hormone) action
• Stimulates Leydig cells
• Maintains intratesticular testosterone
• Preserves testicular size

Typical Protocols

• **Standard**: 250-500 IU 2-3 times per week
• **Minimal**: 250 IU every other day
• **For fertility**: 500-1000 IU 3 times per week

When Necessary

• Planning fatherhood
• Concern about testicular atrophy
• Subjective feelings of "fullness"

Cautions

• May increase estradiol
• Requires E2 monitoring
• Possible desensitization at high doses

Kisspeptin

**Alternative to hCG** — stimulates endogenous HPG axis.

Mechanism

• Stimulates GnRH release
• More physiological approach
• Potentially better for long-term use

Status

• Being researched for TRT use
• Limited availability
• Promising alternative

Aromatase Inhibitors

**Why**: Controlling testosterone to estradiol conversion.

Anastrozole (Arimidex)

Most commonly used in TRT.

Indications:

• E2 > 40-50 pg/mL with symptoms
• Excess estrogen symptoms (gynecomastia, water retention)

Typical dosages:

• 0.25-0.5 mg twice weekly
• Titrated by E2 level

Important:

• DO NOT use preventively
• Too low E2 is a problem (joints, libido, mood)
• Target: 20-35 pg/mL (individual)

Alternatives

• **Letrozole** — more potent, rarely needed in TRT
• **Exemestane** — steroidal AI, irreversible

SERMs (Selective Estrogen Receptor Modulators)

Clomiphene (Clomid)

Use in TRT context:

• Monotherapy as injection alternative
• Stimulating endogenous production
• Fertility preservation

Protocol:

• 12.5-25 mg every other day or daily
• Monitoring testosterone and LH

Limitations:

• May raise E2
• Less stable T levels
• Visual side effects rare

Tamoxifen (Nolvadex)

• Used for gynecomastia
• 10-20 mg/day when needed
• Not for routine TRT use

General Principles

1. **Less = better** — add medications only when indicated
2. **Monitoring** — regular labs determine necessity
3. **Individual approach** — no universal protocols
4. **Symptoms matter more than numbers** — treat the patient, not the lab

TRT Laboratory Monitoring

Proper monitoring is key to safe and effective therapy.

Baseline Labs Before Starting TRT

Hormone Panel

| Marker | Why | Reference | |--------|-----|-----------| | **Total testosterone** | Confirm deficiency | 300-1000 ng/dL | | **Free testosterone** | Bioavailable fraction | > 50 pg/mL | | **SHBG** | Binding assessment | 20-60 nmol/L | | **Estradiol** | Baseline level | 20-35 pg/mL | | **LH** | Cause differentiation | 1.5-9.0 mIU/mL | | **FSH** | HPG axis assessment | 1.5-12.0 mIU/mL | | **Prolactin** | Rule out tumor | 2-18 ng/mL |

Metabolic Panel

| Marker | Why | |--------|-----| | **Fasting glucose** | Rule out diabetes | | **HbA1c** | Long-term glucose control | | **Lipid profile** | Baseline CV risk | | **ALT/AST** | Liver function | | **Creatinine/Urea** | Kidney function |

Hematology

| Marker | Why | Limit | |--------|-----|-------| | **Hematocrit** | Thrombosis risk | < 54% | | **Hemoglobin** | Polycythemia | < 18 g/dL | | **PSA** | Prostate screening | < 4 ng/mL |

On-Therapy Monitoring

Testing Frequency

• **First 3 months**: every 4-6 weeks
• **Stabilization**: every 3-6 months
• **Long-term**: every 6-12 months

When to Test

For peak assessment:

• Enanthate/Cypionate: 24-48 hours post-injection

For trough assessment:

• Immediately before next injection
• Preferred method for titration

Target Values on TRT

| Marker | Target | Notes | |--------|--------|-------| | **Total T (trough)** | 500-800 ng/dL | Individual | | **Free T** | > 100 pg/mL | Above mid-reference | | **Estradiol** | 20-35 pg/mL | Symptomatic correction | | **Hematocrit** | < 52% | Critical < 54% | | **PSA** | Stable | Rise > 1 ng/mL/yr = workup |

Red Flags

Require Immediate Attention:

• Hematocrit > 54%
• Rapid PSA rise
• Polycythemia symptoms (headaches, facial flushing)
• Sleep apnea (symptom worsening)

What to Do:

1. Reduce dose or injection frequency
2. Therapeutic phlebotomy (blood donation)
3. Urology consult for PSA changes
4. Sleep apnea workup

Practical Recommendations

1. **Keep a diary** — injection dates, doses, lab timing
2. **Standardize testing** — same time, same lab
3. **Look at trends** — not individual values
4. **Symptoms + labs** — together give the full picture

Detailed examination protocols by TRT stage — from initial checkup to long-term monitoring.

Official Clinical Guidelines

Main TRT guidelines are developed by the Endocrine Society and American Urological Association (AUA).

Endocrine Society Guidelines (2018)

Therapy Indications

Hypogonadism diagnostic criteria:

1. Testosterone deficiency symptoms
2. Confirmed by **two** morning testosterone measurements < 300 ng/dL
3. Tests in morning (8-10 AM), fasting

Recommended Medications

| Medication | Dosage | Frequency | |------------|--------|-----------| | Testosterone enanthate/cypionate | 75-100 mg | Weekly | | Testosterone enanthate/cypionate | 150-200 mg | Every 2 weeks | | Testosterone undecanoate | 750-1000 mg | Every 10-14 weeks | | Gel (AndroGel, Testim) | 50-100 mg | Daily | | Patch (Androderm) | 2-6 mg | Daily |

Monitoring (ES recommendations)

• **3-6 months**: Testosterone, hematocrit
• **12 months**: Full profile + PSA
• **Annually**: Testosterone, hematocrit, PSA

Contraindications

Absolute:

• Breast cancer
• Prostate cancer
• Planning fatherhood (relative)
• Severe sleep apnea (untreated)
• Heart failure (class III-IV)

Relative:

• Hematocrit > 50%
• Severe BPH symptoms
• PSA > 4 ng/mL without workup

AUA Guidelines (2018)

Differences from Endocrine Society

| Aspect | Endocrine Society | AUA | |--------|-------------------|-----| | **T threshold** | < 300 ng/dL | < 300 ng/dL | | **Focus** | Endocrinology | Urology | | **PSA screening** | > 40 years | > 55 years (or earlier with risk factors) |

AUA Monitoring Recommendations

1. **Baseline**:

• Two morning T measurements
• PSA (when indicated)
• Hematocrit

1. **On therapy**:

• Testosterone at 3-6 months
• Hematocrit every 6-12 months
• PSA — as indicated

Hematocrit Management

If hematocrit > 54%:

1. Stop therapy
2. Therapeutic phlebotomy
3. Resume with lower dose
4. Consider more frequent injections

Practical Aspects

Starting Doses (conservative approach)

• **Enanthate/Cypionate**: 100 mg/week (split into 2 injections)
• **Titration**: every 6-8 weeks based on labs

Efficacy Assessment

Symptoms to monitor:

• Energy (usually first improvement)
• Libido (2-4 weeks)
• Erections (4-8 weeks)
• Body composition (3-6 months)
• Mood (1-3 months)

When to Adjust

• Symptoms not improving at adequate levels
• Side effects
• Hematocrit > 52%
• PSA changes

Protocols from the Biohacking Community

⚠️ **Important**: These protocols are not official medical recommendations. They are based on biohacking community practice and require monitoring under physician supervision.

Microdosing (Daily/EOD)

Concept

Frequent small doses for maximum level stability.

Protocol

• **Dose**: 10-20 mg daily or 20-30 mg every other day
• **Total weekly**: ~100-140 mg
• **Method**: Subcutaneous injections (SubQ)

Advantages

• Minimal level fluctuations
• Less estradiol conversion
• Stable well-being
• Less AI need

Disadvantages

• Daily injections
• Requires discipline
• More syringe use

SubQ (Subcutaneous Injections)

Why SubQ Instead of IM

| Aspect | SubQ | IM | |--------|------|-----| | Needle | 27-31G, 0.5" | 22-25G, 1-1.5" | | Pain | Minimal | Moderate | | Scarring | Rare | Possible | | Absorption | Slightly slower | Standard |

Technique

1. Insulin syringe 29-31G
2. Abdomen or thigh
3. Small volumes (< 0.5 mL)
4. Injection site rotation

Data

• Studies show comparable bioavailability
• Many clinics have switched to SubQ for TRT

Creams and Gels

Scrotal Application

Applying testosterone cream to the scrotum.

Theory:

• Thin skin → better absorption
• High 5α-reductase → more DHT
• May improve libido and function

Protocol:

• Testosterone cream 10-20%
• 50-100 mg 1-2 times daily
• Applied to scrotum

Cautions:

• Elevated DHT → possible hair loss
• Transfer to partners (contact)
• Non-standard approach

Combined Protocols

Testosterone + hCG

Standard combination for fertility preservation:

• Testosterone: 100-150 mg/week
• hCG: 250-500 IU 2-3 times per week

Testosterone + Clomiphene

For maintaining endogenous function:

• Testosterone: 80-100 mg/week
• Clomiphene: 12.5-25 mg every other day

Pregnenolone and DHEA

Pregnenolone

• "Mother" hormone
• May decrease during TRT
• Supplement: 25-50 mg/day

DHEA

• Precursor to testosterone and estrogen
• Supplement: 25-50 mg/day
• Level monitoring

Risks and Cautions

General risks of "advanced" protocols:

1. Lack of long-term data
2. Individual variability
3. Potential unknown consequences

Minimizing risks:

• Regular monitoring (labs)
• Working with competent physician
• Conservative start
• Documenting changes

What Works for Most

Simple effective protocol:

1. Testosterone enanthate/cypionate 100-150 mg/week
2. Split into 2-3 injections
3. SubQ injections
4. hCG 250-500 IU 2x/week (if fertility needed)
5. Labs every 3 months first year

TRT FAQ

General Questions

Q: Will I need to take testosterone for life?

A: If you have primary hypogonadism (testicular problem) — most likely yes. With secondary hypogonadism, axis recovery through hCG, clomiphene, or therapy break is possible. However, after prolonged TRT (> 1-2 years), recovery may be incomplete.

---

Q: Does TRT cause infertility?

A: TRT suppresses LH and FSH production, which reduces or stops spermatogenesis. This is reversible in most cases but takes time (3-12 months after discontinuation). Adding hCG can preserve spermatogenesis during therapy.

---

Q: What are the side effects?

A: Most common:

• Elevated hematocrit (erythrocytosis)
• Acne
• Water retention
• Lipid profile changes
• Testicular atrophy (without hCG)

Less common:

• Gynecomastia
• Hair loss (if predisposed)
• Mood changes

---

Q: How fast to expect results?

A: Timeline:

• **2-3 weeks**: Libido, energy changes
• **4-6 weeks**: Mood, sleep improvement
• **3-6 months**: Body composition changes
• **6-12 months**: Maximum muscle and bone effects

---

Practical Questions

Q: Are insulin syringes suitable for TRT?

A: Yes, for SubQ injections insulin syringes (29-31G) are ideal. For IM, you typically need 23-25G, 1-1.5 inch needles.

---

Q: Can I fly with testosterone?

A: Yes, with a prescription. Keep in original packaging with prescription. Rules may vary by country — check in advance.

---

Q: How to store testosterone?

A: Room temperature (59-77°F), protect from light. Do not freeze. After opening — usually up to 28 days (check instructions).

---

Q: What if I miss an injection?

A: Take the injection as soon as possible. If close to next dose — skip the missed one and continue schedule. Don't double the dose.

---

Monitoring

Q: When to test — peak or trough?

A: Both are useful:

• **Trough (before injection)**: Shows minimum level, better for titration
• **Peak (24-48h after)**: Shows maximum, useful for dose assessment

Most doctors prefer trough.

---

Q: Which testosterone to measure — total or free?

A: Both. Total testosterone is the standard marker. Free is important with:

• High SHBG
• Obesity
• Symptom-total T mismatch

---

Q: How often to test?

A:

• First 6 months: every 4-6 weeks
• Stable therapy: every 3-6 months
• Long-term: every 6-12 months

---

Lifestyle

Q: Can I drink alcohol on TRT?

A: In moderation — yes. Excessive alcohol lowers testosterone and increases aromatization. Recommended: ≤ 2 drinks per day for men.

---

Q: Do I need to change my diet?

A: Optimal diet enhances TRT effects:

• Adequate protein (1.6-2.2 g/kg)
• Healthy fats (for hormones)
• Minimal processed foods
• Enough zinc, vitamin D, magnesium

---

Q: Can I train as usual?

A: Yes, and it's recommended. Strength training is synergistic with TRT for muscle gain and fat loss. Adapt load to your condition.

Key Takeaways

Principles of Successful TRT

1. **Diagnosis First**

• Two confirmed low T levels
• Rule out secondary causes
• Complete workup before starting

1. **Individual Approach**

• No universal dose
• Symptoms matter more than numbers
• Titrate based on response

1. **Level Stability**

• Frequent injections (2-3x/week) better than rare
• SubQ comparable to IM
• Enanthate/cypionate — gold standard

1. **Monitoring Required**

• Hematocrit — main safety marker
• PSA — for men > 40 years
• Regular labs = early correction

1. **Less Is More**

• Start with low doses
• Add medications only when indicated
• AI — only with symptoms

Pre-TRT Checklist

• [ ] Two morning fasting T tests
• [ ] Complete hormone panel (LH, FSH, prolactin, E2)
• [ ] Hematocrit and PSA
• [ ] Endocrinologist/urologist consultation
• [ ] Fertility discussion
• [ ] Understanding long-term commitment

Red Lines

Contact doctor immediately if:

• Hematocrit > 54%
• Thrombosis symptoms (leg pain/swelling, shortness of breath)
• Urination problems
• Chest pain
• Sudden mood changes

Resources

Scientific Sources:

• Endocrine Society Guidelines
• American Urological Association
• PubMed Central

Calculators:

• Steroidcalc.com — level calculation by protocol
• Unit converters (ng/dL ↔ nmol/L)

Conclusion

TRT with the right approach is an effective tool for improving quality of life in men with hypogonadism. Key to success: proper diagnosis, individual protocol, and regular monitoring.

**Remember**: This material is an educational resource, not a substitute for specialist consultation. Any therapy should be conducted under the supervision of a qualified physician.

---

*Last updated: February 2026*

*If this material was helpful, share it with those who might benefit.*